Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
STAA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.50 - $39.35
Previous CloseN/A
Volume326.32K
Average Volume (3M)2.23M
Market Cap
$1.35B
Enterprise Value$688.52M
Total Cash (Recent Filing)$222.76M
Total Debt (Recent Filing)$36.68M
Price to Earnings (P/E)55.8
Beta0.88
Next Earnings
Oct 29, 2025EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding49,553,036
10 Day Avg. Volume5,375,408
30 Day Avg. Volume2,225,071
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)2.99
Price to Sales (P/S)3.79
P/FCF Ratio-155.08
Enterprise Value/Market Cap0.51
Enterprise Value/Revenue2.47
Enterprise Value/Gross Profit3.33
Enterprise Value/Ebitda-9.09
Forecast
1Y Price Target
$24.86Price Target Upside-8.80% Downside
Rating ConsensusHold
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
China Market RecoveryThere are signs that the refractive market in China has improved.
Financial PerformanceSTAA's 2Q25 revenue beat consensus with growth of 10%.
Strategic AcquisitionThe acquisition makes sense strategically, and valuation appears attractive for a differentiated technology.
Bears Say
Dilutive Acquisition ImpactThe deal will be dilutive in the first year and modestly accretive in the second year.
Macro UncertaintyThe company formally withdrew guidance given the macro uncertainty and the management transition.
US And Japan Market SoftnessIn-line ex-China sales was the main neutral/negative — softness came from the US and Japan.
Staar Surgical News
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $13.50 and its highest was $39.35 in the past 12 months.
What is Staar Surgical’s market cap?
Staar Surgical’s market cap is $1.35B.
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Oct 29, 2025 which is in 79 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Aug 06, 2025. The company reported -$0.339 earnings per share for the quarter, beating the consensus estimate of -$0.561 by $0.222.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Overvalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is 0.19.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,553,036 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of -$0.339 in its last earnings report, beating expectations of -$0.561. Following the earnings report the stock price went up 0.186%.
Which hedge fund is a major shareholder of Staar Surgical?
Currently, no hedge funds are holding shares in STAA
Staar Surgical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$24.86 (-8.80% Downside)
$24.86 (-8.80% Downside)
Blogger Sentiment
Bullish
STAA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 36.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.2%
Last 30 Days ▲ 4.9%
Last 30 Days ▲ 4.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.45%
12-Months-Change
Fundamentals
Return on Equity
-25.55%
Trailing 12-Months
Asset Growth
-14.62%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Company (STAA) is a leading provider in the healthcare sector, specializing in the development, manufacture, and marketing of implantable lenses for the eye. The company primarily focuses on developing products for vision correction, including implantable collamer lenses (ICLs) used to treat myopia, hyperopia, and astigmatism. STAAR Surgical's innovative lens technology provides an alternative to traditional vision correction methods such as glasses and contact lenses, catering to a global market.
STAA Company Deck
STAA Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strategic management changes and positive sales growth outside China, along with cost optimization efforts and increased manufacturing capacity. However, significant revenue decline in China, lower profitability, decreased gross margin, and tariff challenges presented notable challenges.View all STAA earnings summariesSTAA Stock 12 Month Forecast
Average Price Target
$24.86
▼(-8.80% Downside)
Technical Analysis
Baxter International
―
Intuitive Surgical
―
Masimo
―
Resmed
―
Bausch + Lomb Corporation
―
Ownership Overview
55.22% Insiders
16.39% Mutual Funds
0.37% Other Institutional Investors
2.21% Public Companies and
Individual Investors